Key result
Steatotic liver disease linked to ~89% lower odds of pathogenic LDLR variants in suspected FH.
Why the study?
Does the presence of steatotic liver disease predict a lower likelihood of pathogenic LDLR gene mutations in young Korean adults with suspected familial hypercholesterolemia?
Cross-Sectional (n=111)
No
Does the presence of steatotic liver disease predict a lower likelihood of pathogenic LDLR gene mutations in young Korean adults with suspected familial hypercholesterolemia?
Answers are grounded in this paper and cite their sources.
Steatotic liver disease is inversely associated with pathogenic LDLR mutations in young adults with suspected FH, suggesting hepatic steatosis assessment may help prioritize candidates for costly genetic testing.
Background: Familial hypercholesterolemia (FH) is underdiagnosed in young adults, and universal genetic testing is costly.We evaluated whether steatotic liver disease (SLD) could predict low-density lipoprotein receptor (LDLR) mutations in suspected FH. Methods:We retrospectively analyzed 111 Korean military personnel aged 19-30 years who underwent LDLR sequencing and SLD assessment using controlled attenuation parameter (CAP) and hepatic steatosis index.Results: Pathogenic LDLR variants were identified in 23.4% of participants.Compared to non-carriers, carriers had significantly lower CAP values (245.2 dB/m vs. 273.9dB/m, P=0.004) and SLD prevalence (52.9% vs. 82.0%,P=0.025).Multivariable logistic regression confirmed SLD was independently associated with lower odds of variant carriage (adjusted odds ratio, 0.11; 95% confidence interval, 0.02 to 0.56; P=0.009).Clustering analysis showed the highest variant prevalence in lean, non-SLD individuals. Conclusion: SLD was inversely associated with genetically confirmed FH. IncorporatingSLD assessment may help prioritize genetic testing in populations with a high prevalence of SLD or limited access to sequencing resources.
No takes yet. Share an insight, caveat, or question.
Han et al. (2026) conducted a cross-sectional in Suspected familial hypercholesterolemia (n=111). Steatotic liver disease (SLD) vs. Absence of steatotic liver disease (non-SLD) was evaluated on Pathogenic LDLR gene variant carriage (OR 0.11, 95% CI 0.02-0.56, p=0.009). Steatotic liver disease was independently associated with lower odds of pathogenic LDLR variant carriage in young adults with suspected FH.
Synapse has enriched 10 related papers. Consider them for comparative context: